Hillevax Inc
General ticker "HLVX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $95.3M
Hillevax Inc does not follow the US Stock Market performance with the rate: -37.2%.
Estimated limits based on current volatility of 2.0%: low 1.83$, high 1.90$
Factors to consider:
- Current price 80.2% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [9.46$, 19.86$]
- 2024-12-30 to 2025-12-30 estimated range: [7.46$, 16.37$]
Short-term HLVX quotes
Long-term HLVX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $53.43MM | $65.11MM | $133.34MM |
| Operating Income | $-53.43MM | $-65.11MM | $-133.34MM |
| Non-Operating Income | $-8.57MM | $4.37MM | $9.78MM |
| Interest Expense | $2.84MM | $3.41MM | $2.39MM |
| R&D Expense | $10.01MM | $45.91MM | $106.68MM |
| Income(Loss) | $-62.00MM | $-60.75MM | $-123.57MM |
| Profit(Loss) | $-62.00MM | $-60.75MM | $-123.57MM |
| Stockholders Equity | $-100.76MM | $267.23MM | $265.52MM |
| Assets | $127.16MM | $317.21MM | $344.43MM |
| Operating Cash Flow | $-7.29MM | $-61.99MM | $-86.78MM |
| Capital expenditure | $2.81MM | $6.51MM | $10.75MM |
| Investing Cash Flow | $-2.81MM | $-6.51MM | $-94.64MM |
| Financing Cash Flow | $134.21MM | $224.97MM | $118.70MM |
| Earnings Per Share* | $-2.82 | $-6.83 | $-3.04 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.